International Society for Cellular Therapy

29.09.2011 – 13:03
International Society for Cellular Therapy (ISCT) Leads Roundtable With Major US Payors, Healthcare Providers and Industry to Initiate a Collaboration to Address Cell Therapy Product Reimbursement
Vancouver (ots/PRNewswire) - The interest of many insured US citizens was represented by participation of payor organizations including Anthem Blue Cross Blue Shield, LifeTrac and OptumHealth. In keeping with its mission to drive the commercialization of cell therapy products and advance global patient access, ISCT ...
mehr
19.01.2011 – 14:02
International Society for Cellular Therapy (ISCT) Launches Inaugural Cell Therapy Commercial Development Focus Group on Peripheral Vascular Disease
Vancouver (ots/PRNewswire) - In keeping with its commitment to connect industry, regulatory experts, therapeutic societies and translational centers to advance emerging cellular therapies, ISCT announces its first commercial development focus group addressing Cell Therapies for Peripheral Vascular ...
mehr
16.08.2010 – 12:00
International Society for Cellular Therapy (ISCT) Joins Forces With Roche and Genzyme to Launch Cell Therapy Industry Partnership
Vancouver, August 16, 2010 (ots/PRNewswire) - Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment within the ...
mehr